The Final Edition of July 2021's Idealease Safety Bulletin provides important information and resources, including:

• Prescription Drugs and Commercial Motor Vehicle Operation Do Not Always Mix
• MROs May Sound the Alarm Even if a DOT Test is Negative
• A Third Certification Body Will Test ELDs for Use in Canada
• CVSA Announces Dates for Brake Safety Week
• FMCSA Proposes Rule Changes for Vehicle Safety Technologies
• FMCSA Issues Final Rule on Electronic Exchange of Driver History Records

Click here to read the entire bulletin online or access a PDF version to read, print and/or distribute to your team through the image below.  Remember to sign up to receive the newest bulletins each week to your email inbox! 

Want to review past bulletins? Click here to access the full archive. 

MANAGING DRIVERS WITH PRESCRIPTION DRUGS

Prescription drugs and Commercial Motor Vehicle Operation Do Not Always Mix! 

Opioid overdoses continue to challenge our country and prescription medications have increased substantially over the past 50 years.  The average person had 2 prescriptions dispensed over a year in 1950. That number in 2018 increased to 17.6!!!! In 2004, hydrocodone was the largest single prescription dispensed at 92.7 MILLION prescriptions!

Being that medications can have a direct effect on driving skills, along with the operation of a CMV, managers of commercial truck drivers must understand and be aware of the medications their drivers take on a regular basis. 

Resource: https://www.fmcsa.dot.gov/regulations/drug-alcohol-testing-program

What can you do?

• communicate with your drivers!
• be aware of drivers' physical conditions
• if drivers are prescribed medications due to injury, ensure doctor is aware that employee operates a CMV
• request assistance from your Medical Review Officer
• develop a relationship with your medical care providers so they understand job requirements of your employees

Partial list of legal drugs that can impair one's ability to drive:

• Anti-anxiety medication
• Amphetamines
• Barbiturates
• Stimulants
• Narcotic pain medications
• Allergy medicines
• Blood sugar medicines
• Antidepressants
• Tranquilizers
• Blood pressure medicines
• Motion sickness medication
• Ulcer medication
• Antibiotics
• Anti-seizure medicines
• Paregoric
• Anti-nausea medicine
• Sedatives
• Cough syrups
• Alcohol-containing medicines
• Caffeine-containing medicines
• Decongestants 

Resource: www.drugs.com - side effects, drug information and more! 

FMCSA FAQs:

What medications disqualify a CMV driver?
Can a CMV driver be disqualified for using a legally prescribed drug?
Access 21 CFR 1308.11 (Controlled Substance Schedule I) 

For further assistance, please contact the FMCSA's Physical Qualifications Division at fmcsamedical@fmcsa.dot.gov or (202) 366-4001. 

MROs May Sound the Alarm Even if a DOT Test is Negative

The addition of four commonly prescribed opioids to the DOT drug testing panel effective January 1, 2018, has left some drivers and carriers with unanswered questions, especially when the Medical Review Officer (MRO) calls into question a driver's fitness for duty.

What drugs are prohibited?

Sections 382.213, 392.4, and 391.41(b)(12) state that any drug, including over-the-counter medications, that affects a driver's ability to safely operate a commercial motor vehicle (CMV) is strictly prohibited.

Schedule I drugs, such as marijuana, are strictly prohibited - even if permissible under state laws.

On the other hand, the regulations allow for the use of a non-Schedule I controlled substance, providing:

• It was legally prescribed to the driver, and
• The prescribing medical practitioner:
  • is aware of the driver's job duties, and
  • has indicated it will not interfere with the driver's ability to safely operate a commercial motor vehicle.

CDL driver's opioid prescription

DOT testing procedures for safety-sensitive positions (i.e., CDL positions) recently added hydrocodone, hydromorphone, oxymorphone, and oxycodone to the DOT testing panel. All are on Schedule II of Controlled Substances.

If a DOT urine collection reveals one of these four controlled substances, the MRO will verify that the prescription meets the exception in Section 382.213 by contacting the medical practitioner who wrote the script. The test is reported to the motor carrier as a negative. However, the story doesn't necessarily end there.

Recent changes to 49 CFR Part 40 now offer procedures for MROs who see continued use of the prescription as a safety risk. In such instances, the MRO will notify the driver that he or she has five days to arrange an alternative to the current medication. If the driver fails to act on this request and the five days elapse or the prescribing physician is unable to offer a suitable replacement, the MRO has been given the discretion to call the medication into question. He or she may contact the motor carrier, certified medical examiner (ME) that qualified the driver under the Federal Motor Carrier Safety Regulations, a Substance Abuse Professional evaluating the employee as part of the return-to-duty process, a DOT agency, or the National Transportation Safety Board in the course of an accident investigation.

What are an employer's options?

When a motor carrier is contacted by the MRO about the driver's prescription drug use, the motor carrier has not been given instructions on how to proceed.

The motor carrier has the option of sending the driver for a new DOT physical anytime his or her qualifications come into question. This is in accordance with Section 391.45(c). The driver, however, must be honest about his or her prescription drug use on the health history portion of the exam form. The Medical Examiner makes the final determination, and could:

• Use the exception and fully qualify the driver,
• Request another medication and withhold certification until it is rectified, or
• Medically disqualify the driver.

Since the test is negative (and the driver has a current medical card), the company, in theory, could opt to do nothing. But, the Medical review officer  may wind up contacting the company each time the driver has a drug screen since the safety risk, in the MRO's opinion, has not been resolved.

And, if this driver is in a serious crash, it could dredge up claims of negative entrustment since the motor carrier has knowledge of a potential safety risk.

FMCSA Proposes Rule Changes for Vehicle Safety Technologies

On Tuesday, July 6, 2021, Federal Motor Carrier Safety Administration (FMCSA) proposed to change the rules for windshield-mounted cameras in commercial motor vehicles (CMVs). The proposed changes would make filing for an exemption and prior company-specific exemptions (including J.J. Keller and Associates, Inc.) unnecessary. Interested parties must comment by August 5, 2021. A request from Daimler Trucks North America prompted the proposal.

The changes would define vehicle safety technology as “fleet-related incident management systems, performance or behavior management systems, speed management systems, lane departure warning systems, forward collision warning or mitigation systems, active cruise control systems, transponder, brake warning systems, automatic emergency braking, driver camera systems, attention assist warnings, Global Positioning Systems, and traffic sign recognition systems.”

If accepted as proposed, carriers could install the devices on the interior of windshields of CMVs:

Not more than 216 mm (8.5 inches instead of 4 inches) below the upper edge of the area swept by the windshield wipers; or
Not more than 175 mm (7 inches) above the lower edge of the area swept by the windshield wipers; and
Outside of the driver’s sightlines to the road and highway signs and signals.

FMCSA proposed adding certain vehicle safety technologies to accommodate vehicle manufacturers’ advancements in driver assistance technologies. Also added were GPS units, which drivers often mount to the dashboard.
 

FMCSA Issues Final Rule on Electronic Exchange of Driver History Records

The Federal Motor Carrier Safety Administration has issued a final rule requiring State Driver Licensing Agencies to implement a system and practices for the exclusively electronic exchange of driver history record information through the Commercial Driver’s License Information System (CDLIS), including the posting of convictions, withdrawals, and disqualifications.  86 Fed. Reg. 38937 (July 23, 2021).

The final rule gives States until August 22, 2024 to comply with this requirement.  Congress had mandated that the States adopt this type of electronic information exchange in 2012; this rulemaking codifies that mandate in federal regulation.

The FMCSA notice states that while all states currently have the technical capability to transmit the driver history record information through CDLIS, some State Driver Licensing Agencies are unable to do so when the driver information (e.g., driver’s CDL number, date of birth, or State of record), required for CDLIS to validate and accept the electronic record, is incorrect or missing. Under those circumstances, States must rely on alternative methods of transmission, such as the U.S. mail.